Study Information
| Title: | Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis  |
| Status: | Recruiting participants |
| Conditions: | Relapsing Remitting Multiple Sclerosis |
| Interventions: | Drug: Interferon β 1a; Drug: DAC HYP |
| Health Topics: | Multiple Sclerosis |
Contact Information
Research Site
Springfield, MA
Research Site
Worchester, MA